Rx Manufacturing Safety Bill Resurfaces Without Inspection Fees
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's foreign and domestic oversight powers would increase under the legislation, which has been stripped down in an apparent effort to speed passage.